/
/
/

Ipca Laboratories Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1,950.00
Volume (₹)43,343.00
High (₹)1,967.60
Upper Circuit2,347.30
Low (₹)1,944.20
Lower Circuit1,564.90
Prev Close1,956.10
52W High (₹)2,001.50
Price1,962.50
52W Low (₹)1,251.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)49604.20 Cr
Div. Yield (%)0.31
PE Ratio37.87
Debt to Equity0.09
Price to Book5.05
Book Value317.72
EPS (TTM)51.63
Face Value1.00
ROE (%)15.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
IPCALABNSE
LTP
1W Low
1W High
Market cap (₹)
1901-19 (-0.99%)
1900.10
1984.80
4,56,833Cr
9180.5-58.5 (-0.63%)
9087
9467
2,45,426Cr
4862-188 (-3.72%)
4850
5066
1,87,320Cr
1131-60 (-5.04%)
1125.10
1187
1,13,217Cr
1380.9-42.6 (-2.99%)
1376.70
1426.10
1,12,212Cr
1851.5-87 (-4.49%)
1811.70
1949
1,01,155Cr
2122.1-49.4 (-2.27%)
2118.10
2192
97,626Cr
2337-45.9 (-1.93%)
2335
2419.20
96,859Cr
1162.9-15.1 (-1.28%)
1154.40
1179.90
96,406Cr
1657.6+12.3 (0.75%)
1622.60
1717
93,614Cr
1962.5+12.2 (0.63%)
1907.90
2001.50
49,604Cr

Key Highlights of Ipca Laboratories Ltd Balance Sheet

Ipca Laboratories Ltd balance sheet discloses shareholders' funds of ₹25.37Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹25.37Cr, and the reserves and surplus of the company is ₹7953.98Cr.

The company has its non-current liabilities with total liabilities of ₹9775.5Cr as of 2026-03-31.

The current liabilities are ₹1418.75Cr as of 2026-03-31. At the same time, current assets are ₹3995Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹2188.39Cr and tangible assets of ₹2969.35Cr, provided in the Ipca Laboratories Ltd financial statements.